4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;2-[2-(6-methyl-2-pyridinyl)-2H-pyrrol-3-yl]-1,5-naphthyridine;1-[3-(6-methyl-2-pyridinyl)-4-quinolin-4-ylpyrazol-1-yl]-2-phenylethanethione
C66H50N12O3S — CID 159566363
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;2-[2-(6-methyl-2-pyridinyl)-2H-pyrrol-3-yl]-1,5-naphthyridine;1-[3-(6-methyl-2-pyridinyl)-4-quinolin-4-ylpyrazol-1-yl]-2-phenylethanethione
4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;2-[2-(6-methyl-2-pyridinyl)-2H-pyrrol-3-yl]-1,5-naphthyridine;1-[3-(6-methyl-2-pyridinyl)-4-quinolin-4-ylpyrazol-1-yl]-2-phenylethanethione (PubChem CID 159566363) has the molecular formula C66H50N12O3S and a molecular weight of 1091.27 g/mol. Its IUPAC name is 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;2-[2-(6-methyl-2-pyridinyl)-2H-pyrrol-3-yl]-1,5-naphthyridine;1-[3-(6-methyl-2-pyridinyl)-4-quinolin-4-ylpyrazol-1-yl]-2-phenylethanethione.
Molecular Properties
| Compound Name | 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;2-[2-(6-methyl-2-pyridinyl)-2H-pyrrol-3-yl]-1,5-naphthyridine;1-[3-(6-methyl-2-pyridinyl)-4-quinolin-4-ylpyrazol-1-yl]-2-phenylethanethione |
|---|---|
| PubChem CID | 159566363 |
| Molecular Formula | C66H50N12O3S |
| Molecular Weight | 1091.27 g/mol |
| Exact Mass | 1090.38 |
| IUPAC Name | 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;2-[2-(6-methyl-2-pyridinyl)-2H-pyrrol-3-yl]-1,5-naphthyridine;1-[3-(6-methyl-2-pyridinyl)-4-quinolin-4-ylpyrazol-1-yl]-2-phenylethanethione |
| SMILES | Cc1cccc(-c2nn(C(=S)Cc3ccccc3)cc2-c2ccnc3ccccc23)n1.Cc1cccc(C2N=CC=C2c2ccc3ncccc3n2)n1.NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1 |
| InChI | InChI=1S/C26H20N4S.C22H16N4O3.C18H14N4/c1-18-8-7-13-24(28-18)26-22(20-14-15-27-23-12-6-5-11-21(20)23)17-30(29-26)25(31)16-19-9-3-2-4-10-19;23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17;1-12-4-2-5-17(21-12)18-13(9-11-20-18)14-7-8-15-16(22-14)6-3-10-19-15/h2-15,17H,16H2,1H3;1-11H,12H2,(H2,23,27)(H,25,26);2-11,18H,1H3 |
| InChIKey | MHGCTRJIAILPRW-UHFFFAOYSA-N |
| XLogP | 13.06 |
| TPSA | 197.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 82 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1091.27 |
| LogP ≤ 5 | 13.06 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159566363 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.